PLSH
Price
$0.05
Change
-$0.01 (-16.67%)
Updated
Sep 5 closing price
Capitalization
1.11M
VTRS
Price
$10.41
Change
-$0.09 (-0.86%)
Updated
Sep 8, 01:38 PM (EDT)
Capitalization
12.24B
63 days until earnings call
Interact to see
Advertisement

PLSH vs VTRS

Header iconPLSH vs VTRS Comparison
Open Charts PLSH vs VTRSBanner chart's image
Panacea Life Sciences Holdings
Price$0.05
Change-$0.01 (-16.67%)
Volume$4.02K
Capitalization1.11M
Viatris
Price$10.41
Change-$0.09 (-0.86%)
Volume$1.78K
Capitalization12.24B
PLSH vs VTRS Comparison Chart in %
Loading...
PLSH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLSH vs. VTRS commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLSH is a Hold and VTRS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (PLSH: $0.05 vs. VTRS: $10.50)
Brand notoriety: PLSH and VTRS are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: PLSH: 39% vs. VTRS: 88%
Market capitalization -- PLSH: $1.11M vs. VTRS: $12.24B
PLSH [@Pharmaceuticals: Generic] is valued at $1.11M. VTRS’s [@Pharmaceuticals: Generic] market capitalization is $12.24B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLSH’s FA Score shows that 1 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • PLSH’s FA Score: 1 green, 4 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, VTRS is a better buy in the long-term than PLSH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLSH’s TA Score shows that 5 TA indicator(s) are bullish while VTRS’s TA Score has 4 bullish TA indicator(s).

  • PLSH’s TA Score: 5 bullish, 2 bearish.
  • VTRS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PLSH is a better buy in the short-term than VTRS.

Price Growth

PLSH (@Pharmaceuticals: Generic) experienced а +2.55% price change this week, while VTRS (@Pharmaceuticals: Generic) price change was -0.47% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.10%. For the same industry, the average monthly price growth was +9.01%, and the average quarterly price growth was +87.11%.

Reported Earning Dates

VTRS is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($12.2B) has a higher market cap than PLSH($1.11M). PLSH YTD gains are higher at: 109.200 vs. VTRS (-12.394). VTRS has more cash in the bank: 406M vs. PLSH (243K). PLSH has less debt than VTRS: PLSH (11.3M) vs VTRS (14.5B).
PLSHVTRSPLSH / VTRS
Capitalization1.11M12.2B0%
EBITDA-2.87MN/A-
Gain YTD109.200-12.394-881%
P/E RatioN/A236.20-
Revenue4.14MN/A-
Total Cash243K406M0%
Total Debt11.3M14.5B0%
FUNDAMENTALS RATINGS
PLSH vs VTRS: Fundamental Ratings
PLSH
VTRS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
12
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
6144
P/E GROWTH RATING
1..100
291
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (12) in the null industry is in the same range as PLSH (41). This means that VTRS’s stock grew similarly to PLSH’s over the last 12 months.

VTRS's Profit vs Risk Rating (100) in the null industry is in the same range as PLSH (100). This means that VTRS’s stock grew similarly to PLSH’s over the last 12 months.

VTRS's SMR Rating (96) in the null industry is in the same range as PLSH (100). This means that VTRS’s stock grew similarly to PLSH’s over the last 12 months.

VTRS's Price Growth Rating (44) in the null industry is in the same range as PLSH (61). This means that VTRS’s stock grew similarly to PLSH’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is in the same range as PLSH (29). This means that VTRS’s stock grew similarly to PLSH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PLSHVTRS
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
66%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
57%
MACD
ODDS (%)
Bullish Trend 4 days ago
70%
Bearish Trend 4 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
62%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
68%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
59%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
PLSH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
THC196.183.66
+1.90%
Tenet Healthcare Corp
GLAD26.05-0.16
-0.61%
Gladstone Capital Corp
HUT25.38-0.23
-0.90%
Hut 8 Corp
MGYR17.30-0.20
-1.14%
Magyar Bancorp
EVOK5.21-0.08
-1.51%
Evoke Pharma, Inc.

PLSH and

Correlation & Price change

A.I.dvisor tells us that PLSH and SHPH have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PLSH and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSH
1D Price
Change %
PLSH100%
-18.28%
SHPH - PLSH
24%
Poorly correlated
-1.17%
VTRS - PLSH
20%
Poorly correlated
+1.65%
BFRI - PLSH
17%
Poorly correlated
+0.64%
STEK - PLSH
8%
Poorly correlated
-3.45%
EAPIF - PLSH
6%
Poorly correlated
N/A
More